TGFB1 and neoplasm: TGF-β-mediated NK cell conversion into Eomes- ILC1 with increased expression levels of inhibitory receptors may represent an additional mechanism to reduce NK cell cytotoxicity in mouse tumor models (29), while a third mechanism is the inhibition of signaling pathways downstream of pro-inflammatory cytokines (30, 36, 111, 112).